Mingqiu Chen
No. 420, Fuma Road
Fuzhou, 350014, China
Fuzhou, 350014, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Data-driven prognostic factors analysis and personalized follow-up strategies for post-progression survival in locally advanced esophageal squamous cell carcinoma after definitive chemoradiotherapy.
Journal: Annals of medicine
Published: January 02, 2026
Definitive chemoradiotherapy plus immune checkpoint inhibitors for locally advanced unresectable esophageal squamous cell carcinoma: survival and progression patterns in a propensity-matched cohort.
Journal: Frontiers in immunology
Published: December 31, 2025
Validation and refinement of the 8th edition of the AJCC staging system for esophageal squamous cell carcinoma treated with definitive IMRT or chemo-IMRT: a Chinese multi-institutional retrospective study.
Journal: Radiation oncology (London, England)
Published: August 28, 2025
Survival analysis of small cell carcinoma of the esophagus: a 15-year retrospective study from a high-incidence region.
Journal: Journal of gastrointestinal oncology
Published: May 26, 2025
Anlotinib promotes CD4 + T cell infiltration and enhances the anti-tumor effect of PD-1 blockade in lung cancer.
Journal: Immunologic research
Published: January 13, 2025
Camrelizumab plus chemotherapy versus chemoradiotherapy as neoadjuvant therapy for resectable esophageal squamous cell carcinoma: Phase 2 randomized trial (REVO).
Journal: Nature communications
Published: December 05, 2024
Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer.
Journal: Thoracic cancer
Published: November 27, 2023
Clinical definition of secondary resistance to immunotherapy in non-small cell lung cancer.
Journal: Thoracic cancer
Published: October 25, 2023
Efficacy and complications of single-port thoracoscopic minimally invasive esophagectomy in esophageal squamous cell carcinoma: a single-center experience.
Journal: Scientific reports
Published: June 13, 2023
Hypoxia-induced factor-1α promotes radioresistance of esophageal cancer cells by transcriptionally activating LINC01116 and suppressing miR-3612 under hypoxia.
Journal: Journal of biochemical and molecular toxicology
Published: December 13, 2022
Systemic Immune-Inflammatory Index, Tumor-Infiltrating Lymphocytes, and Clinical Outcomes in Esophageal Squamous Cell Carcinoma Receiving Concurrent Chemoradiotherapy.
Journal: Journal of immunology research
Published: November 30, 2022
Last Updated: 09/26/2026